Doorish Ophthalmic Technologies, Inc. (DOT) is a company dedicated to the development of a prosthesis that will restore sight, to some useful degree, to those suffering from blindness caused by, among other things, Age-related Macular Degeneration (AMD), Retinitis Pigmentosa (RP), and several genetic conditions. DoT is incorporated in the State of New York. DOT is no relation to Second Sight in California.